✦ LIBER ✦

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

✍ Scribed by Kathryn R. Wagner; James L. Fleckenstein; Anthony A. Amato; Richard J. Barohn; Katharine Bushby; Diana M. Escolar; Kevin M. Flanigan; Alan Pestronk; Rabi Tawil; Gil I. Wolfe; Michelle Eagle; Julaine M. Florence; Wendy M. King; Shree Pandya; Volker Straub; Paul Juneau; Kathleen Meyers; Cristina Csimma; Tracey Araujo; Robert Allen; Stephanie A. Parsons; John M. Wozney; Edward R. LaVallie; Jerry R. Mendell

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 536 KB
Volume: 63
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.21338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single muscle fiber contractile properti

Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029

✍ Lisa S. Krivickas; Ronan Walsh; Anthony A. Amato 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract Myostatin inhibitors are being investigated as treatments for myopathies. We assessed single muscle fiber contractile properties before and after 6 months of study drug in 6 patients with facioscapulohumeral, Becker, and limb‐girdle muscular dystrophy. Five of the patients received MYO‐

Quantification of asenapine and three me

Quantification of asenapine and three metabolites in human plasma using liquid chromatography–tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects

✍ Theo de Boer; Erik Meulman; Henri Meijering; Jaap Wieling; Peter Dogterom; Holge 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

## ABSTRACT The development and validation of methods for determining concentrations of the antipsychotic drug asenapine (ASE) and three of its metabolites [__N__‐desmethylasenapine (DMA), asenapine‐N^+^‐glucuronide (ASG) and 11‐__O__‐sulfate‐asenapine (OSA)] in human plasma using LC‐MS/MS with aut